SlideShare a Scribd company logo
NHS Innovations
South East
Map that App!
Oxford Academic Health Science Network
29 January 2014
Dr Anthony Hill, Senior Innovation Manager
NHS Innovations
South East
NHS Innovations
South East
http://venturebeat.com/2008/08/08/defcon-
excuse-me-while-i-turn-off-your-pacemaker/
NHS Innovations
South East
Who are the “Digital Omnivores”?
• Main device - smartphone or tablet? Smartphone
(77%), tablets up from 12% in 2012 to 23% in 2013*
• Use of tablet PCs in healthcare (global) grew 27% in
2012 and is expected to increase to $1.7 billion for
2013‡
Source: *Adobe global 2013 Mobile Consumer Survey, ‡Kalorama
Information, **BMC Medical Informatics and Decision Making Journal, ‡‡ EPC
Health Media
• 79% medical students, 75% percent of junior doctors
own a smartphone**
• US smartphone use by doctors: 81% in 2010 to 91% in
2012. EU doctors: 44% in 2010 to 81% in 2012 in
Europe‡‡
NHS Innovations
South East
• Users downloaded 44 million mobile health (mHealth)
apps downloads in 2012
• 142 million mHealth downloads predicted by 2016.*
• Top mHealth publishers: 3 million free and 300,000 paid
downloads in the USA on the iOS platform.
• Wider mobile health market will reach $8 billion by
2018**
Source: *Juniper Research, **Global Data
Proposed Agenda
App Stats!
NHS Innovations
South East
Wild West or Gold Rush?
Health App
• 97,000 mHealth applications
listed on 62 full catalogue app
stores
• Many apps are unvalidated
Patient / consumer safety?
Medical Devices?
Data privacy issues?
Security?
• Uptake and expectations are surging
NHS Innovations
South East
Health apps: where are we ?
NHS Innovations
South East
STAGE 1 – PRE-DEVELOPMENT
STAGE 2 – DESIGN & DEVELOPMENT
STAGE 3 – USER TESTING
STAGE 4 – STAKEHOLDER REVIEW
STAGE 5 – MEDICAL DEVICE PROCESS*
STAGE 6 – EXTERNAL DEPLOYMENT
*Subject to nature of mobile app
NHS Innovations
South East
NHS Innovations
South East
Internal Development or
Outsourced?
Proceed to STAGE 2
Business Justification Case
Go / No Go
Decision
No
Identify Suppliers / collaborators?
Procurement process?
Stakeholder /Target
Audience Analysis
Am I “reinventing the Wheel”?
Competitive Analysis
(Validated Apps)
What are your goals? Why develop
a mobile app?
Needs Assessment
Value Proposition?
Patient /organisational benefit ?
Resources? Costs? Risks?
Commercialisation strategy?
Intellectual Property in app? –
copyright in code, database
rights, trademark branding
Sustainability? Ongoing support
and costs?
Go / No Go
Decision
No Project stakeholders? User
Profiles? Public Patient
Involvement needed at this
stage? Hardware /platform
preference?
NHS Innovations
South East
STAGE 2 – DESIGN & DEVELOPMENT
NHS Innovations
South East
Early functions /user interface / website
framework
Mocked up prototype screens permitting user
interaction feedback
Linking mobile app into existing or new ICT
infrastructure. Interoperability?
Wireframe Development
Screenshots
Code Generation
User Training Proceed to STAGE 3
System Integration & testing
API Usage, App Store optimisation?
User & System requirements
Functionality? Data flows?
Public Patient Involvement?
USE CASES. Commercialisation route? Data &
Device Security? Medical Device? (see stage 5)
Hardware Specifications?
NHS Innovations
South East
May 2012: Audit of Android fragmentation
Almost 4000 android devices involving 600 different brands
Source: http://opensignal.com/reports/fragmentation.php
NHS Innovations
South East
Version Codename API Distribution
2.2 Froyo 8 1.30%
2.3.3 -
Gingerbread 10 21.20%
2.3.7
3.2
Honeycomb 13 0.10%
4.0.3 -
Ice Cream
Sandwich
15 16.90%
4.0.4
4.1.x
Jelly Bean
16 35.90%
4.2.x 17 15.40%
4.3 18 7.80%
4.4 KitKat 19 1.40%
Data collected during a 7-day period ending on January 8, 2014.
Any versions with less than 0.1% distribution are not shown.
Application Programming Interface (API) fragmentation
Source: Dashboard from
Developer.android.com
NHS Innovations
South East
STAGE 3 – USER TESTING
NHS Innovations
South East
User Testing
Refine Prototype
Back to STAGE 2 Proceed to STAGE 4
Development
Complete? YES
Development
Complete? NO
• Usability? Performance? Hardware? Communications?
• Contribution to technical file for CE marking
• USER EXPERIENCE IS KEY!
NHS Innovations
South East
NHS Innovations
South East
STAGE 4 – STAKEHOLDER REVIEW
NHS Innovations
South East
Clinical Safety assessment?
Systems review?
Security review?
Quality check?
Internal Deployment
Within organisation*
Proceed to STAGE 6
Pass Reviews?
YES
Pass Reviews?
NO
Stakeholder Review /
Clinical Validation
*Does not require CE marking
at this stage
Medical Device?
YES
Proceed to STAGE 5
Medical Device?
NO
Back to STAGE 2
NHS Innovations
South East
STAGE 5 – MEDICAL DEVICE PROCESS
NHS Innovations
South East
Medical Devices Directive
Under clause 2(a) of the Medical Devices Directive, a
medical device is defined as follows:
• Includes any software, whether used alone or in
combination, including that specifically for
diagnostic and/or therapeutic purposes and
necessary for its proper application, intended by
the manufacturer to be used for human beings for
the purpose of:
• diagnosis, prevention, monitoring, treatment or
alleviation of disease,
• diagnosis, monitoring, treatment, alleviation of or
compensation for an injury or handicap,
• investigation, replacement or modification of the
anatomy or of a physiological process,
• Control of conception;
NHS Innovations
South East
NHS Innovations
South East
STAGE 6 – EXTERNAL DEPLOYMENT
NHS Innovations
South East
App stores are a means of both
selling and deploying mobile
apps to targeted users
• More NHS organisations are implementing
mobile management solutions (MAM / MDM)
to deploy and manage app access, and also
mobile hardware.
• NHS England has launched the NHS Health
Apps Library, lifestyle apps that had been
reviewed to ensure they were clinically safe.
Deployment
NHS Innovations
South East
• Free?
Worldwide mobile advertising is forecast to reach $24.5B by 2016*
• In-app purchasing or freemium?
71% of App store revenue was from in-app purchases in 2013*
• Paid
Users who plan to make app purchases from device*:
iPhone 69% Android 53% BlackBerry 35% Windows 32%
Source: *Localytics.com
Commercialisation Approaches
• Consumers are increasingly reluctant to pay for
apps, particularly when so many apps are available
and appear to be free.
• App sustainability?
• Services or Product business stream
NHS Innovations
South East
NHS Innovations
South East
What we do
Thanks to Rhiannon Cox, Alan Kennedy and
Chris Sawyer and Oxford AHSN
Accelerated Commercialisation of Non-Patent
Intellectual Property Associated with Healthcare Apps
Event: 18th March 2014, Academic Centre, Maidstone
& Tunbridge Wells NHS Trust
Details to follow at http://innovationssoutheast.nhs.uk

More Related Content

PPTX
Medica presentation mobile medical apps
PPTX
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
PPTX
Overview on healthcare applications
PPTX
Oxford UK Medical App Usability
PPTX
Pathways for patient facing apps using ResearchKit, HealthKit and CareKit
PDF
The invasion of mobile medical apps: A 5-Year Outlook
PDF
Challenges of Healthcare Application Development
PDF
Synoptek health assistant_mobile_app_business_case_april_2020
Medica presentation mobile medical apps
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Overview on healthcare applications
Oxford UK Medical App Usability
Pathways for patient facing apps using ResearchKit, HealthKit and CareKit
The invasion of mobile medical apps: A 5-Year Outlook
Challenges of Healthcare Application Development
Synoptek health assistant_mobile_app_business_case_april_2020

What's hot (20)

PPTX
Whats driving growth in telemedicine and software testing trends
PDF
The integration of mobile and medical technologies
PDF
#MWC15Health showcase innovation session 1a pdf
PDF
Is mHealth Prescribing: Dead or Thriving?
PPTX
Apple ResearchKit
PDF
Eleven BioTherapeutics
PPTX
Realizing and sustaining disruptive Innovations by Gabe Rijpma,
PDF
#MWC15Health mittal parekh & spyros skiadopoulos Globo
PPTX
What's Next In Connected Health
PPT
Wiring Healthcare: eHealth & Innovation Trends : Presentation for Bulgaria
PDF
Telehealth Trends & Remote Patient Monitoring
PPTX
Quiz Program by Quiz Masters - K Ganapathy & Arvind Sivaramakrishnan
PPT
000519 csfb e medasiaroadshowfinal9 hm
DOC
Marketing project final
PDF
Biz Model for Google Lens
PPTX
mHealth App Developer Economics 2015 by research2guidance
PPTX
The Essentials to Successful User-Centric Development
PDF
7 BEST FDA APPROVED HEALTH APPS
Whats driving growth in telemedicine and software testing trends
The integration of mobile and medical technologies
#MWC15Health showcase innovation session 1a pdf
Is mHealth Prescribing: Dead or Thriving?
Apple ResearchKit
Eleven BioTherapeutics
Realizing and sustaining disruptive Innovations by Gabe Rijpma,
#MWC15Health mittal parekh & spyros skiadopoulos Globo
What's Next In Connected Health
Wiring Healthcare: eHealth & Innovation Trends : Presentation for Bulgaria
Telehealth Trends & Remote Patient Monitoring
Quiz Program by Quiz Masters - K Ganapathy & Arvind Sivaramakrishnan
000519 csfb e medasiaroadshowfinal9 hm
Marketing project final
Biz Model for Google Lens
mHealth App Developer Economics 2015 by research2guidance
The Essentials to Successful User-Centric Development
7 BEST FDA APPROVED HEALTH APPS
Ad

Similar to Oxford AHSN Map My App Event 29th Jan 2014 (20)

PDF
NISE Outline App Roadmap 18- Mar 2014
PPTX
Mobile apps for pharma and healthcare by ARworks
PPTX
8 Lessons Learned from Developing mHealth Apps
PDF
Mobile developement
PPTX
UK mHealth app assessment
PDF
Tech lifescinews june2014
PDF
How Mobile App Development Ensures Patient’s Healthcare.
PDF
Mobile Apps and the Healthcare World
PDF
Infographic: Healthcare goes mobile
PDF
How to build a mobile app for patients health tracking
PDF
Improving Healthcare App Development Reasons Why You Should Invest in it.pdf
PDF
Mobile Apps for Patients Care! Top Things to Consider
PDF
Stephen Welch
PDF
mHealth - The Mobile App Strategy Healthcare
PDF
Improving Healthcare App Development- Reasons Why You Should Invest in it.
PDF
Masal 2013 the twenty-first century black bag - posted presentation
PDF
Improving Healthcare App Development Reasons Why You Should Invest in it.pdf
PPT
Health Guardian - Little Green Monsters
PPTX
What is a good app_Trappenburg 2.0
PPTX
University of California Center for Health Leadership Mobile workshop
NISE Outline App Roadmap 18- Mar 2014
Mobile apps for pharma and healthcare by ARworks
8 Lessons Learned from Developing mHealth Apps
Mobile developement
UK mHealth app assessment
Tech lifescinews june2014
How Mobile App Development Ensures Patient’s Healthcare.
Mobile Apps and the Healthcare World
Infographic: Healthcare goes mobile
How to build a mobile app for patients health tracking
Improving Healthcare App Development Reasons Why You Should Invest in it.pdf
Mobile Apps for Patients Care! Top Things to Consider
Stephen Welch
mHealth - The Mobile App Strategy Healthcare
Improving Healthcare App Development- Reasons Why You Should Invest in it.
Masal 2013 the twenty-first century black bag - posted presentation
Improving Healthcare App Development Reasons Why You Should Invest in it.pdf
Health Guardian - Little Green Monsters
What is a good app_Trappenburg 2.0
University of California Center for Health Leadership Mobile workshop
Ad

Recently uploaded (20)

PDF
Traveri Digital Marketing Seminar 2025 by Corey and Jessica Perlman
PPT
Chapter four Project-Preparation material
PDF
Types of control:Qualitative vs Quantitative
PPT
Data mining for business intelligence ch04 sharda
PPTX
Belch_12e_PPT_Ch18_Accessible_university.pptx
PDF
BsN 7th Sem Course GridNNNNNNNN CCN.pdf
PPTX
Business Ethics - An introduction and its overview.pptx
PPTX
job Avenue by vinith.pptxvnbvnvnvbnvbnbmnbmbh
PDF
pdfcoffee.com-opt-b1plus-sb-answers.pdfvi
PDF
20250805_A. Stotz All Weather Strategy - Performance review July 2025.pdf
PPTX
Lecture (1)-Introduction.pptx business communication
PDF
MSPs in 10 Words - Created by US MSP Network
PDF
Roadmap Map-digital Banking feature MB,IB,AB
PDF
kom-180-proposal-for-a-directive-amending-directive-2014-45-eu-and-directive-...
PPTX
ICG2025_ICG 6th steering committee 30-8-24.pptx
PPTX
The Marketing Journey - Tracey Phillips - Marketing Matters 7-2025.pptx
PDF
How to Get Funding for Your Trucking Business
PDF
Dr. Enrique Segura Ense Group - A Self-Made Entrepreneur And Executive
PDF
Stem Cell Market Report | Trends, Growth & Forecast 2025-2034
PDF
Chapter 5_Foreign Exchange Market in .pdf
Traveri Digital Marketing Seminar 2025 by Corey and Jessica Perlman
Chapter four Project-Preparation material
Types of control:Qualitative vs Quantitative
Data mining for business intelligence ch04 sharda
Belch_12e_PPT_Ch18_Accessible_university.pptx
BsN 7th Sem Course GridNNNNNNNN CCN.pdf
Business Ethics - An introduction and its overview.pptx
job Avenue by vinith.pptxvnbvnvnvbnvbnbmnbmbh
pdfcoffee.com-opt-b1plus-sb-answers.pdfvi
20250805_A. Stotz All Weather Strategy - Performance review July 2025.pdf
Lecture (1)-Introduction.pptx business communication
MSPs in 10 Words - Created by US MSP Network
Roadmap Map-digital Banking feature MB,IB,AB
kom-180-proposal-for-a-directive-amending-directive-2014-45-eu-and-directive-...
ICG2025_ICG 6th steering committee 30-8-24.pptx
The Marketing Journey - Tracey Phillips - Marketing Matters 7-2025.pptx
How to Get Funding for Your Trucking Business
Dr. Enrique Segura Ense Group - A Self-Made Entrepreneur And Executive
Stem Cell Market Report | Trends, Growth & Forecast 2025-2034
Chapter 5_Foreign Exchange Market in .pdf

Oxford AHSN Map My App Event 29th Jan 2014

  • 1. NHS Innovations South East Map that App! Oxford Academic Health Science Network 29 January 2014 Dr Anthony Hill, Senior Innovation Manager
  • 4. NHS Innovations South East Who are the “Digital Omnivores”? • Main device - smartphone or tablet? Smartphone (77%), tablets up from 12% in 2012 to 23% in 2013* • Use of tablet PCs in healthcare (global) grew 27% in 2012 and is expected to increase to $1.7 billion for 2013‡ Source: *Adobe global 2013 Mobile Consumer Survey, ‡Kalorama Information, **BMC Medical Informatics and Decision Making Journal, ‡‡ EPC Health Media • 79% medical students, 75% percent of junior doctors own a smartphone** • US smartphone use by doctors: 81% in 2010 to 91% in 2012. EU doctors: 44% in 2010 to 81% in 2012 in Europe‡‡
  • 5. NHS Innovations South East • Users downloaded 44 million mobile health (mHealth) apps downloads in 2012 • 142 million mHealth downloads predicted by 2016.* • Top mHealth publishers: 3 million free and 300,000 paid downloads in the USA on the iOS platform. • Wider mobile health market will reach $8 billion by 2018** Source: *Juniper Research, **Global Data Proposed Agenda App Stats!
  • 6. NHS Innovations South East Wild West or Gold Rush? Health App • 97,000 mHealth applications listed on 62 full catalogue app stores • Many apps are unvalidated Patient / consumer safety? Medical Devices? Data privacy issues? Security? • Uptake and expectations are surging
  • 7. NHS Innovations South East Health apps: where are we ?
  • 8. NHS Innovations South East STAGE 1 – PRE-DEVELOPMENT STAGE 2 – DESIGN & DEVELOPMENT STAGE 3 – USER TESTING STAGE 4 – STAKEHOLDER REVIEW STAGE 5 – MEDICAL DEVICE PROCESS* STAGE 6 – EXTERNAL DEPLOYMENT *Subject to nature of mobile app
  • 10. NHS Innovations South East Internal Development or Outsourced? Proceed to STAGE 2 Business Justification Case Go / No Go Decision No Identify Suppliers / collaborators? Procurement process? Stakeholder /Target Audience Analysis Am I “reinventing the Wheel”? Competitive Analysis (Validated Apps) What are your goals? Why develop a mobile app? Needs Assessment Value Proposition? Patient /organisational benefit ? Resources? Costs? Risks? Commercialisation strategy? Intellectual Property in app? – copyright in code, database rights, trademark branding Sustainability? Ongoing support and costs? Go / No Go Decision No Project stakeholders? User Profiles? Public Patient Involvement needed at this stage? Hardware /platform preference?
  • 11. NHS Innovations South East STAGE 2 – DESIGN & DEVELOPMENT
  • 12. NHS Innovations South East Early functions /user interface / website framework Mocked up prototype screens permitting user interaction feedback Linking mobile app into existing or new ICT infrastructure. Interoperability? Wireframe Development Screenshots Code Generation User Training Proceed to STAGE 3 System Integration & testing API Usage, App Store optimisation? User & System requirements Functionality? Data flows? Public Patient Involvement? USE CASES. Commercialisation route? Data & Device Security? Medical Device? (see stage 5) Hardware Specifications?
  • 13. NHS Innovations South East May 2012: Audit of Android fragmentation Almost 4000 android devices involving 600 different brands Source: http://opensignal.com/reports/fragmentation.php
  • 14. NHS Innovations South East Version Codename API Distribution 2.2 Froyo 8 1.30% 2.3.3 - Gingerbread 10 21.20% 2.3.7 3.2 Honeycomb 13 0.10% 4.0.3 - Ice Cream Sandwich 15 16.90% 4.0.4 4.1.x Jelly Bean 16 35.90% 4.2.x 17 15.40% 4.3 18 7.80% 4.4 KitKat 19 1.40% Data collected during a 7-day period ending on January 8, 2014. Any versions with less than 0.1% distribution are not shown. Application Programming Interface (API) fragmentation Source: Dashboard from Developer.android.com
  • 15. NHS Innovations South East STAGE 3 – USER TESTING
  • 16. NHS Innovations South East User Testing Refine Prototype Back to STAGE 2 Proceed to STAGE 4 Development Complete? YES Development Complete? NO • Usability? Performance? Hardware? Communications? • Contribution to technical file for CE marking • USER EXPERIENCE IS KEY!
  • 18. NHS Innovations South East STAGE 4 – STAKEHOLDER REVIEW
  • 19. NHS Innovations South East Clinical Safety assessment? Systems review? Security review? Quality check? Internal Deployment Within organisation* Proceed to STAGE 6 Pass Reviews? YES Pass Reviews? NO Stakeholder Review / Clinical Validation *Does not require CE marking at this stage Medical Device? YES Proceed to STAGE 5 Medical Device? NO Back to STAGE 2
  • 20. NHS Innovations South East STAGE 5 – MEDICAL DEVICE PROCESS
  • 21. NHS Innovations South East Medical Devices Directive Under clause 2(a) of the Medical Devices Directive, a medical device is defined as follows: • Includes any software, whether used alone or in combination, including that specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings for the purpose of: • diagnosis, prevention, monitoring, treatment or alleviation of disease, • diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap, • investigation, replacement or modification of the anatomy or of a physiological process, • Control of conception;
  • 23. NHS Innovations South East STAGE 6 – EXTERNAL DEPLOYMENT
  • 24. NHS Innovations South East App stores are a means of both selling and deploying mobile apps to targeted users • More NHS organisations are implementing mobile management solutions (MAM / MDM) to deploy and manage app access, and also mobile hardware. • NHS England has launched the NHS Health Apps Library, lifestyle apps that had been reviewed to ensure they were clinically safe. Deployment
  • 25. NHS Innovations South East • Free? Worldwide mobile advertising is forecast to reach $24.5B by 2016* • In-app purchasing or freemium? 71% of App store revenue was from in-app purchases in 2013* • Paid Users who plan to make app purchases from device*: iPhone 69% Android 53% BlackBerry 35% Windows 32% Source: *Localytics.com Commercialisation Approaches • Consumers are increasingly reluctant to pay for apps, particularly when so many apps are available and appear to be free. • App sustainability? • Services or Product business stream
  • 27. NHS Innovations South East What we do Thanks to Rhiannon Cox, Alan Kennedy and Chris Sawyer and Oxford AHSN Accelerated Commercialisation of Non-Patent Intellectual Property Associated with Healthcare Apps Event: 18th March 2014, Academic Centre, Maidstone & Tunbridge Wells NHS Trust Details to follow at http://innovationssoutheast.nhs.uk

Editor's Notes

  • #3: We all know that mobile computing has really taken off in the last few year and has developed beyond recognition since those early days The demand for and use of smartphone and tablet or mini tablet devices impacts on many aspects of our every day lives as consumers.
  • #4: We now use software in a manner that influences our lives, our decision making and in some cases controls our healthThis is taken from a 2008 article describing a conference where hackers managed to demonstrate with ease how they could potentially control an implanted pacemaker device via the on board software.We are becoming increasingly dependent as a society on some of these technology innovations but may be playing catchup on some of the implications of use.
  • #5: So who are some of the healthcare users or digital omnivores in this current landscape. This is a selection of some of the many stats that are out there.Not surprisingly younger generations have embraced the technology but uptake continues to increase across several clinical professions and some of the data is shown here. In the case of EU doctors the % smartphone usage doubled in 2 years from 2010.Another trend that is gaining momentum is the increased use of tablets or mini tablets in healthcare.
  • #6: So we are here this evening to talk about mobile apps and a roadmap.Let’s quickly look at some health app stats
  • #7: So the uptake and use of apps is continuing at pace. Expectations are high. As a dedicated NHS IP and Innovation management service we are inundated with app ideas which probably account for about 35% of our disclosures.This feels like it has all of the signs of the early days of the gold rush but in reality it is more like the lawless wild west. It’s not just me saying this, the academic literature is filled with articles from clinical groups and professional bodies expressing concern regarding the use of apps, quality and clinical safety. The wanted poster shows a picture of the uChek urine analysis app. Users use the phone camera. Take a picture which then is analysed by the app and out pops the analysis on the app to influence clinical treatment. This high profile app (for all of the wrong reasons) fell fowl of the FDA regulator in the US as it was deemed to be medical device and was unvalidatedand no FDA approval was sought. apple has started taking a stronger line on health apps registration in their apps store to the extent that there is evidence suggesting that certain type of health apps will only be accepted if they have been suitably validated and the clinical or pharmaceutical data has been provided from a reliable source.So times are changing!
  • #8: This brings us on to the roadmap. The health and efficiency rewards associated with the technology can be substantial. So we hope that that roadmap is a means by which people are encouraged and explore their app ideas but that they go into the venture with their eyes open and know where they can get further assistance
  • #9: We have current broken the roadmap down into 6 distinct stages. Those of you familiar with software development may feel that stage 3 users testing is actually part of the stage 2 development phase, you are not necessarily wrong but we have separated out for a reason which I will come back to later.
  • #11: Key stage to build a solid foundation and also to stress test whether you should proceed with the app development and whether you have stakeholder buy-inNeeds Assessment: Where are you at the moment, what are your goals? Gap analysis. Do you really need to develop the app?Competitive analysis: what else is out there? Is it validated? Does it meet your needs? Followed by a go no go decisionStakeholder analysis - Who are the stakeholders (individuals or organisations) that need to be involved in the app design and development or kept informed? Who will the app impact on? Is there a hardware or platform preference? Will the target audience pay for the app, want a free app, or expect it to be bundled into an existing service? Does the profile of the target audience lend itself to a particular commercialisation approach?Development – Do you plan to outsource the development or develop in-house?Business justification case – proportionate to the nature and complexity of the app. A number of factors to consider.In a brief and clear statement can you articulate what the mobile app is, what need it is addressing and what it means in terms of value to the organisation or to the patient / consumer? E.g. For patients with advanced rheumatoid arthritis the iDocstar is a mobile app used by clinicians to radically simplify the complex process of patient assessment for biologic therapies, guide patients onto appropriate treatments, and save the organisation £xxx,000 per annum.Patient / organisational benefit – eg supports CG50 or specific NHS or PH outcomes framework
  • #13: We have added a very simple interpretation of a design and development process here. In reality it will often involve iterative loops and most software developers will use their own rapid and usually agile methodology to develop the app in a cost effective manner.User Requirements Specification or User Requirements Document (URD): This document specifies what the app really needs to do for the customer or end user and what the developer will provide. Use Cases are often used to walk through the user steps or interactions with the proposed app. The Systems Requirements Specification seeks to identify understand and plan for the organisation and user impact of the proposed app and the manner in which it will integrate with other systems and the business environment. Data stored on device? A survey by HP suggests that more than 86% of apps tested from the app store showed a variety of security vulnerabilities. ICO document, “Privacy in mobile apps: guidance for apps developers” sets out clear guidance to assist compliance with the Data Protection Act 1998 (DPA) and ensure users’ privacy. South England NHS Trust – exampleWireframes are rudimentary visual schematics that represent the framework or layout of an app to accomplish a particular purpose or objective. Unlike wireframes screenshots will give the first indication of what the user interface or app screens could look like.
  • #14: Added this to emphasis the need to think about the choice of platform and its implications for app design. Again in many instances the developer will walk you through this.There are different pros and cons associated with the range of platforms currently on the market. Taking android as an example.Samsung 40% share of android market but in theory developing for the android platform? Over 400 different devices currently on the market unlike Microsoft and Apple which have a much smaller ecosystem.
  • #15: Another area that is being debated at the moment and there is a view that android is more suseptable to this. The market may be runnign different versions of the operation system. In terms of Android there are a number of devicess running earlier versions of the OS prior to Kitkat. This may be important as you think about what you are developing and the way the app needs to interact with the device.I am not against android – far from it. One could argue that the lower price of hardward (cf apple) and wider range may make the platform accessible to your target market, but you need to ne aware of some of these factors specific to the platform or ecosystem.
  • #17: STAGE 3 is another critical stage in the roadmap and deliberately separated outRobust user testing is critical not just in terms of functionality but how users react, behave or respond to the app.Remember the user retention stats from earlier 22% never user the app more than once!Word of mouth, family and friend referralPersonalisation of apps is a one of the current topics of conversation as as way of maximising the app impact and user experience.Data from this can also contribute to the technical file for a medical device CE registration.
  • #18: I’ve put this up just to reinforce that the healthcare community is still getting to grips with the way in which apps are being used. This is an article from the 2014 Postgraduate medical journal describing the way in which junior doctors use their smartphones in clinical practice and theoverall usability – so the community is really starting to ask pertinent questions about the way in which mobile devices and apps should be used in day to day practice.
  • #20: The completed app needs to be subjected to a thorough review by relevant stakeholders within (and possibly outside) the organisation. The extent of the review(s) will be dependent on the functionality of the medical app and its intended use.Different types of healthcare apps will require a different approach to manage risk in both the development and use of the app. There are a number of technology standards such as IEC 62304 is a harmonised standard for software design in medical products adopted by the European Union and the United States. The Health and Social Care Information Centre website describes the current clinical risk safety standards. Current legislation requires all NHS organisations and their staff developing mobile applications must manage app development in accordance with relevant information standards.ISB 0129 Clinical Risk Management: its Application in the Manufacture of Health IT SystemsISB 0160 Clinical Risk Management: its Application in the Deployment and Use of Health IT Systems
  • #22: Current guidance allows NHS organisations to be exempt from the Medicines Device Directive and CE marking if the software is being used internally or strictly for research purposes (See MHRA Bulletin 18, February 2011).
  • #23: What if I want to distribute the app elsewhere and perhaps for free?Customer or Developer: who is responsible for compliance with the MDD?Manufacturer means " the person who is responsible for the design, manufacture, packaging and labelling of a device before it is placed on the market under his own name, regardless of whether these operations are carried out by that person himself or on his behalf by a third party". Class I - generally regarded as low riskFor example a standalone clinical decision support app interpreting clinical data, which will influence clinical intervention or interaction with the patient. E.g. Mersey Burns App.Class IIa - generally regarded as medium riskFor example the Withings Blood Pressure App - direct physiological measurements using smartphone enabled blood pressure cuff or short term indwelling urinary catheterEssential requirements stipulate that the principles of safety should be integral to the design of the product and that the product should be suitable for its intended purpose. Manufacturers must provide objective evidence of how the design of the device meets the essential requirements via a technical file. CE marking is a declaration by the manufacturer that the product meets all the appropriate provisions of the relevant legislation implementing certain European Directives.
  • #26: Withings
  • #27: Yes this is a fast moving technology field and it may look a bit scaryThere are a number of credible app developers out there that can guide users around many aspects of the app development and maybe even marketing. However if truth be told this really needs to be done in partnership. Most of the developers will dependent on your to help with clinical input and testing, assistance with clinical safety standards. Also unlike a medical device manufacturer, the medical device directive may also be a new task to grasp for many of the software developers.Don’t be put if this sounds too challenging. Use the roadmap and seek assistance.